Schedule and Critical Path in Clinical Trials

Rebecca Watson, Director and Program Management Team Leader at Johnson & Johnson Innovative Medicine, and Riyesh Menon, Head of Precision Medicine PMO at Amgen, join forces for a panel on schedule management and critical path analysis in clinical trials. Clinical trial timelines are among the most complex and high-stakes schedules in any industry, with delays costing millions per day and potentially affecting patient access to life-saving therapies.

The panelists will share practical approaches to identifying and managing critical path activities in clinical programs, including techniques for scenario modeling, risk-adjusted scheduling, and real-time schedule monitoring. Rebecca and Riyesh will draw on their experiences at two of the world's leading pharmaceutical companies to illustrate how schedule management practices have evolved in response to growing trial complexity.

This session is essential for program managers and planners who manage clinical trial schedules and want to improve their ability to predict, prevent, and respond to schedule risks.